Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kundan Nivangune
Institution:
Lupin Pharmaceuticals (India)
Observed institution:
Lupin Pharmaceuticals (India)
ORCID:
0000-0001-8360-9900
Observed ORCID:
0000-0001-8360-9900
OpenAlex ID:
A5120664044
Evaluating the Real-world Effectiveness and Safety of Formoterol Fumarate and Fluticasone Propionate Combination in Asthma: A Prospective, Multicenter Study
2025
·
Shital Patil
, Rajesh Venkitakrishnan
, et al.
·
Journal of the Association of Physicians of India
·
2
Targeting chronic mucus hypersecretion in respiratory diseases – focus on OPEP devices
2026
·
Rajesh Venkitakrishnan
, Agam Vora
, et al.
·
Respiratory Medicine
Safety and Effectiveness of Indacaterol/Glycopyrronium/Mometasone Dry Powder Inhaler in Asthma: A Prospective Multicenter Phase IV Study
2026
·
Saurabh Karmakar
, Amit S Bhate
, et al.
·
Journal of the Association of Physicians of India
Show more works
View as search
Works count:
3
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type
